MedPath

The effect of Synbiotics and Probiotics supplementation in reducing cardiovascular complications in hemodialysis patients

Phase 2
Conditions
hemoldialysis.
Extracorporeal dialysis
Registration Number
IRCT2017041233393N1
Lead Sponsor
Vice chancellor for research, Ahvaz Jundishapour University of Medical Sciences
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete
Sex
All
Target Recruitment
75
Inclusion Criteria

Inclusion criteria were: willingness to cooperate; at least 3 months renal failure on hemodialysis, 4 hours hemodialysis three times a week; aged between 65-30 years Exclusion criteria: history of kidney transplantation; infection; history of hospitalization in the last month; useing any products or supplements containing probiotics and prebiotics and antibiotics in 1 months; using vitamins fiber omega-3 antioxidants within 3 weeks before or during the study; using nonsteroidal anti-inflammatory drug NSAIDs; progesterone, immunosuppressive drugs; diuretics and corticosteroids; the radiation in the area of small and large bowel; with Being irritable bowel syndrome; Crohn's disease or ulcerative colitis; a severe malnutrition (SGA: C); swelling and bloating

Exclusion Criteria

Not provided

Study & Design

Study Type
interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath